GlassScriptPhysician profile
Anthony Guarino
NPI 1619993847
$10,596.50
in general payments reported to CMS, 2019-2025
31 companies · $1,744 in 2025
The $1,744 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,092 · 2020: $1,573 · 2021: $278 · 2022: $834 · 2023: $1,279 · 2024: $1,797 · 2025: $1,744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,782 · Travel and Lodging: $38.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,781.57 |
| Travel and Lodging | $38.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,977.31 | 2019-2025 | Eterna, Proclaim, Ionicrf |
| Medtronic USA, INC. | $2,093.46 | 2019-2020 | |
| Medtronic, INC. | $572.26 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Foundation Fusion Solutions, LLC | $484.60 | 2024-2025 | |
| Vertos Medical, INC. | $459.37 | 2022-2024 | Mild Device Kit |
| Stimwave Technologies Incorporated | $439.59 | 2019-2021 | |
| Nevro Corp. | $341.64 | 2019-2023 | Senza |
| Boston Scientific Corporation | $291.33 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $290.29 | 2023-2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $240.23 | 2019-2024 | Xtampza, Belbuca |
| Curonix LLC | $239.71 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $152.20 | 2023-2024 | Relistor |
| Zimvie INC. | $138.56 | 2023 | |
| Spinal Simplicity, LLC | $126.23 | 2022 | |
| Flowonix Medical Incorporated | $114.08 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $105.44 | 2023-2025 | Biotronik, Prospera |
| Painteq LLC | $82.70 | 2024 | Painteq |
| Vertiflex, INC. | $76.20 | 2019 | |
| Biodelivery Sciences International, INC. | $66.33 | 2019-2021 | |
| Valinor Pharma, LLC | $53.50 | 2023-2024 | Movantik |
| Emergent Biosolutions INC. | $45.00 | 2021 | |
| Grt US Holding, INC. | $40.36 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $35.28 | 2024-2025 | |
| Depuy Synthes Sales INC. | $23.04 | 2024 | Orthovisc, Monovisc |
| Tersera Therapeutics LLC | $21.76 | 2019 | |
| Stryker Corporation | $15.88 | 2024 | Spinejack |
| Abbvie INC. | $15.39 | 2025 | |
| Allergan, INC. | $14.30 | 2019 | |
| Pfizer INC. | $13.89 | 2023 | |
| Biogen, INC. | $13.79 | 2021 | |
| Kaleo, INC. | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Guarino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.